Home / Inspections / 1237333

1237333

Hikma Pharmaceuticals USA Inc. — FEI 2220525

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 12, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Cherry Hill, NJ (United States)

Facility

Other inspections at this facility

  • 1222115 (VAI Fri Nov 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1176451 (NAI Thu Jul 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1106822 (VAI Tue Sep 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1067645 (NAI Fri Sep 14 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1008043 (NAI Tue Apr 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time))

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
145021 CFR 211.113(a)Procedures for non-sterile drug products
360321 CFR 211.160(b)Scientifically sound laboratory controls